View More Recent Stories

Nov 19, 2015 07:30AM Cancer Genetics, Inc. to Receive $1.2 Million In Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Nov 12, 2015 09:38PM Cancer Genetics Announces Closing of $12 Million Public Offering
Nov 9, 2015 08:00AM Cancer Genetics, Inc. Further Expands the Availability of Genomic Testing as It Signs In-Network Provider Agreements With Blue Cross Blue Shield of North Carolina, Blue Cross Blue Shield Nebraska, and
Nov 6, 2015 02:41PM Cancer Genetics to Report Findings of Two Clinically-Focused Hematological Cancer Studies at the 2015 Association for Molecular Pathology Meeting in Austin, Texas
Oct 28, 2015 07:30AM Cancer Genetics, Inc. Receives Third Patent for Proprietary Genomic FHACT(R) Test, Further Advancing the Detection and Treatment of Cervical and Other HPV-Associated Cancers
Oct 2, 2015 08:00AM Cancer Genetics Receives Bankruptcy Court Approval to Purchase Los Angeles-Based Response Genetics, Inc.
Oct 2, 2015 08:00AM Cancer Genetics Receives Bankruptcy Court Approval to Purchase Los Angeles-Based Response Genetics, Inc.
Sep 17, 2015 04:00AM Cancer Genetics, Inc. to Report Results From Two Independent Studies at the 30th International Papillomavirus Conference & Clinical and Public Health Workshops (HPV 2015)
Sep 17, 2015 04:00AM Cancer Genetics, Inc. to Report Results From Two Independent Studies at the 30th International Papillomavirus Conference & Clinical and Public Health Workshops (HPV 2015)
Sep 2, 2015 07:00AM Cancer Genetics to Present at the Sidoti Emerging Growth Conference on September 2, 2015
Aug 11, 2015 07:30AM Cancer Genetics Announces Strong Second Quarter 2015 Results
Aug 11, 2015 07:30AM Cancer Genetics Announces Strong Second Quarter 2015 Results
Aug 10, 2015 09:51AM Cancer Genetics Announces Agreement in Principle to Acquire the Assets of Response Genetics, Inc. and Its Strong Franchise in Solid Tumor Molecular and Genomic Testing
Aug 4, 2015 08:00AM Cancer Genetics to Report Second Quarter Financial Results on Tuesday, August 11
Aug 4, 2015 08:00AM Cancer Genetics to Report Second Quarter Financial Results on Tuesday, August 11
Aug 3, 2015 08:00AM Cancer Genetics to Present a Unique, Comprehensive NGS-Based Lymphoma Panel at Cancer Genomics Consortium and Cytogenomics Array Group Meeting
Jul 7, 2015 07:00AM Cancer Genetics Inc. Announces a Partnership With ICON's Laboratory Services to Offer Comprehensive Oncology Laboratory Testing and Solutions
Jun 30, 2015 07:30AM Cancer Genetics, Inc. Awarded Largest Clinical Trial in Company History; Will Provide Comprehensive Testing for Global, Multi-Year, Multi-Center Clinical Trial in Chronic Lymphocytic Leukemia (CLL)
Jun 30, 2015 07:30AM Cancer Genetics, Inc. Awarded Largest Clinical Trial in Company History; Will Provide Comprehensive Testing for Global, Multi-Year, Multi-Center Clinical Trial in Chronic Lymphocytic Leukemia (CLL)
Jun 1, 2015 07:30AM Cancer Genetics, Inc. to Present at the Jefferies 2015 Healthcare Conference
Jun 1, 2015 07:30AM Cancer Genetics, Inc. to Present at the Jefferies 2015 Healthcare Conference
May 29, 2015 07:30AM Cancer Genetics to Report Findings of Kidney Cancer Treatment Study From Research Collaboration at the 2015 ASCO Annual Meeting
May 29, 2015 07:30AM Cancer Genetics to Report Findings of Kidney Cancer Treatment Study From Research Collaboration at the 2015 ASCO Annual Meeting
May 26, 2015 07:00AM Cancer Genetics Selected to Power Next-Generation Sequencing Services for ReproCELL, a Global Regenerative Medicine Market Leader, in a Multi-Year Agreement
May 12, 2015 07:30AM Cancer Genetics Announces Strong First Quarter 2015 Results
May 6, 2015 07:30AM Cancer Genetics Enters Into Multi-Year Research Collaboration With Moffitt Cancer Center for Genomics-Based Prediction of Side Effects Associated With Chemotherapy
May 5, 2015 07:30AM Cancer Genetics to Report First Quarter Financial Results on Tuesday, May 12
Apr 30, 2015 07:30AM Cancer Genetics, Inc. Announces Focus::Myeloid(TM) - A Comprehensive Next-Generation Sequencing Based Genomic Panel for the Improved Diagnosis, Prognosis and Clinical Management of Myeloid Cancer Pati
Apr 30, 2015 07:30AM Cancer Genetics, Inc. Announces Focus::Myeloid(TM) - A Comprehensive Next-Generation Sequencing Based Genomic Panel for the Improved Diagnosis, Prognosis and Clinical Management of Myeloid Cancer Pati
Apr 21, 2015 07:30AM Cancer Genetics Expands Next-Generation Sequencing Capabilities in India Through Launch of Solid Tumor Hotspot Panel for Biopharma and Clinical Customers Throughout Asia
Apr 16, 2015 07:45AM Cancer Genetics, Inc. Receives New York State Licensure for FHACT(R) Cervical Cancer Test
Apr 1, 2015 08:25AM Cancer Genetics, Inc. Increases Access to Its Comprehensive Cancer Diagnostic Tests & Services Through Agreement With America's Choice Provider Network(R)
Mar 23, 2015 07:30AM Cancer Genetics, Inc. to Present Results From Three Major Clinical Research Collaborations at USCAP Showcasing the Importance of Genomic Panels for Cancer Identification and Management
Mar 12, 2015 07:30AM Cancer Genetics Announces Record Fourth Quarter and Full-Year 2014 Revenue
View More Recent Stories